Sintx Technologies (SINT) Shares Outstanding (Weighted Average) (2013 - 2026)
Sintx Technologies' quarterly Shares Outstanding (Weighted Average) came in at $4.0 million in Q1 2026, up 126.43% year-on-year from $1.8 million in Q1 2025, and up 44.73% quarter-over-quarter from $2.8 million in Q4 2025.
Sintx Technologies has reported Shares Outstanding (Weighted Average) for 14 years, with the latest figure at $4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 126.43% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 126.43% YoY), and the FY2025 full-year result was $2.8 million, up 274.17% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $4.0 million, up from $2.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $4.0 million in Q1 2026, with the low at $15883.0 in Q2 2023.
- Average Shares Outstanding (Weighted Average) over 5 years is $1.1 million, with a median of $631212.0 recorded in 2024.
- Year-over-year, Shares Outstanding (Weighted Average) slumped 99.0% in 2022 and jumped 4986.57% in 2024.
- Tracing SINT's Shares Outstanding (Weighted Average) over 5 years: stood at $301610.0 in 2022, then sank by 93.81% to $18682.0 in 2023, then jumped by 3867.72% to $741250.0 in 2024, then jumped by 274.17% to $2.8 million in 2025, then surged by 44.73% to $4.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $4.0 million (Q1 2026), $2.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 741,250.00 |
| Sep 30, 2024 | 896,305.00 |
| Jun 30, 2024 | 631,212.00 |
| Mar 31, 2024 | 86,314.00 |
| Dec 31, 2023 | 18,682.00 |
| Sep 30, 2023 | 21,040.00 |
| Jun 30, 2023 | 15,883.00 |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 301,610.00 |
| Sep 30, 2022 | 247,248.00 |
| Jun 30, 2022 | 247,144.00 |
| Mar 31, 2022 | 247,122.00 |
| Dec 31, 2021 | 246,919.00 |
| Sep 30, 2021 | 24.70 Mn |
| Jun 30, 2021 | 24.68 Mn |
| Mar 31, 2021 | 24.67 Mn |
| Dec 31, 2020 | 16.41 Mn |
| Sep 30, 2020 | 13.67 Mn |
| Jun 30, 2020 | 12.12 Mn |
| Mar 31, 2020 | 6.02 Mn |
| Dec 31, 2019 | 1.56 Mn |
| Sep 30, 2019 | 1.27 Mn |
| Jun 30, 2019 | 931,859.00 |
| Mar 31, 2019 | 726,455.00 |
| Dec 31, 2018 | 364,602.00 |
| Sep 30, 2018 | 418,638.00 |
| Jun 30, 2018 | 154,545.00 |
| Mar 31, 2018 | 3.41 Mn |
| Dec 31, 2017 | 2.98 Mn |
| Sep 30, 2017 | 3.02 Mn |
| Jun 30, 2017 | 2.92 Mn |
| Mar 31, 2017 | 2.83 Mn |
| Dec 31, 2016 | 1.54 Mn |
| Sep 30, 2016 | 1.31 Mn |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 932,771.00 |
| Dec 31, 2015 | 362,021.00 |
| Sep 30, 2015 | 110,520.00 |
| Jun 30, 2015 | 141,980.00 |
| Mar 31, 2015 | 1.80 Mn |
| Dec 31, 2014 | 815,997.00 |
| Sep 30, 2014 | 12.69 Mn |
| Jun 30, 2014 | 12.42 Mn |
| Dec 31, 2013 | 534,073.00 |
| Sep 30, 2013 | 571,645.00 |
| Jun 30, 2013 | 532,915.00 |
| Mar 31, 2013 | 418,172.00 |